California-based RNA sequencing company, Cofactor Genomics, is a good example of why it might be the right decision for a company to steer away from big pharma and maybe focus more on consumer diagnostics. Theranos is another company taking full advantage of this angle now.
In a Wired profile, both were featured to highlight how these types of companies are booming right now. Theranos, worth $9 billion, for example, is trying to battle major names in diagnostics like Quest Diagnostics and Laboratory Corporation of America by making blood testing a lot more convenient.
Hey, check out all the engineering jobs. Post your resume today!
